HMGB1 and neoplasm: In a tumor microenvironment, hypoxia-induced release of HMGB1 induces the accumulation of anti-inflammatory M2-like (“alternatively activated”) macrophages and IL-10 production by RAGE signaling, thereby favoring tumor development [24].